Dashboard
Watchlists
Events
Collections
Tools
SIGN UP
SIGN IN
Yichang HEC Changjiang Pharma - 1558 HK
Health Care
Hong Kong
Watchlist
All
Insights
Broker Reports
Sponsored
Refresh
Relevant
bullish
•
Yichang HEC Changjiang Pharma
•
27 Nov 2022 05:15
HEC Pharma (1558 HK): Core Product Saw Volume Recovery in 1H 2022; New Launches to Accelerate Growth
HEC Pharma’s revenue jumped ~6x in 1H22, driven by volume recovery of its core drug Kewei. Going ahead, new generic launches and insulin portfolio...
Tina Banerjee
302 Views
Share
bullish
•
Guangzhou R&F Properties
•
17 Jul 2020 12:49
Full Circulation Of H-Shares - July Update
This update is the latest in a series dating back to Legend's Conversion of Domestic Shares in June 2018, with the most recent addition CPPCC And...
David Blennerhassett
525 Views
Share
bullish
•
Thematic (Sector/Industry)
•
23 Dec 2022 14:05
2022 in Rear Mirror View: Top Performers From My Global Healthcare Coverage Universe
From my coverage universe, two Taiwanese stocks generated 59% and 71% returns in nearly six months. New product launch and geography expansion are...
Tina Banerjee
658 Views
Share
bearish
•
Quantitative Analysis
•
12 Dec 2022 08:15
Hong Kong Connect Flows (Dec 9th): HKEx, Ping An H&T, Tencent, Xiaomi, Li Ning, Meituan
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for HKEx, Ping An H&T, Tencent, Xiaomi, Li Ning, Meituan,...
Ke Yan, CFA, FRM
400 Views
Share
bullish
•
Yichang HEC Changjiang Pharma
•
24 Nov 2021 18:12
Yichang HEC Changjiang Pharma (1558 HK): Multiple New Products Launches Bring New Opportunities
HEC Pharm is on a new growth path through the launch of diabetes and oral HCV drugs. The company has a rich pipeline of innovative drugs, entailing...
Tina Banerjee
200 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v1.8.3
x